Qi Xin

Mecobalamin

Treatment option:

Medically reviewed

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Qi Xin

Property	Description
Active ingredient	Mecobalamin (Methylcobalamin)
Form	Tablet (Oral) or Solution (Parenteral)
Pharmacological class	Neurotrophic Agent, Vitamin B12 Analogue
General purpose	Support and maintenance of the nervous system
Origin	Synthetic, Biologically Active Coenzyme Form

What is Qi Xin and its Core Ingredient, Mecobalamin?

Qi Xin is a specialized pharmaceutical preparation whose active component is Mecobalamin, which is also identified by the generic name Methylcobalamin. This medicine is classified under the World Health Organization's Anatomical Therapeutic Chemical (ATC) system as a Vitamin B12 analogue, which places it within the broader category of antianemic preparations. Mecobalamin is the biologically active coenzyme form of Vitamin B12 (Cobalamin), an essential nutrient. As a single-ingredient product, Qi Xin is formulated to directly supply this specific B12 derivative. Mecobalamin has an established biological role in cellular health, as the medicine supplies a compound required for the body's essential functions.

What Pharmacological Type is Qi Xin and Why Does it Matter?

The pharmacological type of Mecobalamin is highly relevant to its function as a targeted neurotrophic agent. This form of B12 is distinct because it is the specific coenzyme structure utilized by the body, meaning it is readily available to support vital processes without requiring complex metabolic conversion from other forms, such as Cyanocobalamin. This direct mechanism supports its primary role. The general purpose of administering Mecobalamin is to directly support the maintenance and repair of the nervous system—a typical use scenario is to provide neural support in adult patient groups—and to aid in metabolic pathways essential for cell division. The medicine’s composition makes it both a nerve-supporting and an antianemic preparation.

What side effects are possible with Qi Xin?

Possible Side Effects and Safety Information

The official regulatory safety profile for Mecobalamin (Qi Xin) primarily documents adverse reactions that are generally classified as rare or infrequent. These are formally organized into specific System-Organ Classes (SOCs), which describe the body systems affected.

Adverse Reaction Scope

Category	Description
Common/Expected Reactions	Gastrointestinal Disorders (e.g., mild transient diarrhea, nausea, anorexia) and Skin and Subcutaneous Tissue Disorders (e.g., itching, skin rash, transitory exanthema).
Serious Adverse Reactions	Regulatory documents report rare, serious events such as Anaphylactic Shock (particularly with non-oral forms) and Cardiovascular events (e.g., pulmonary edema, congestive heart failure, peripheral vascular thrombosis). These cardiovascular effects are noted as occurring early in treatment when intensely managing severe anemia.

Population-Specific Constraints

The medicine is formally contraindicated in patients with known hypersensitivity to the active substance or to cobalt. A key restriction is the prohibition of use in individuals with Leber's disease (hereditary optic nerve atrophy) due to the risk of severe optic nerve deterioration. Caution is also noted for patients with a history of liver disease and during pregnancy and lactation.

Safety-Related Restrictions

Administration of doses exceeding 10mu g daily may produce a hematologic response that masks the true underlying diagnosis in patients with folate deficiency. Furthermore, the absorption of Mecobalamin may be reduced by certain medications, including specific antibiotics, antacids, and metformin.

This structure communicates that the overall risk is generally low but strictly defines non-negotiable restrictions and highlights the specific rare, serious risks noted in official labeling.

Overdose and Emergency Response

Overdose: What Official Regulatory Information States

Official regulatory documents define an overdose of Qi Xin as a serious medical emergency that can lead to life-threatening outcomes, primarily due to central nervous system (CNS) and respiratory depression.

Documented Manifestations and Life-Threatening Outcomes:

An overdose is characterized by severe clinical signs such as profound sedation, drowsiness, or unresponsiveness, which can progress to stupor or coma. The most dangerous manifestation is life-threatening respiratory depression—slow, shallow, or weak breathing that can stop entirely. Other noted signs include pale, clammy skin and slow, erratic pulse. The official documentation identifies these severe effects as carrying a risk of death.

Mandated Emergency Action:

Regulatory labeling explicitly states that immediate emergency medical help must be sought if an overdose is suspected or if the person exhibits signs like unresponsiveness, slow breathing, or inability to be awakened. The instruction is to call 911 (or local emergency services) immediately.

Official Management:

Regulatory guidance for healthcare professionals specifies that management includes supportive measures to ensure a stable airway and breathing. If the drug is part of a class with a known reversal agent (antidote), the administration of that specific agent is an integral part of the official procedural instruction. Patients must receive continuous observation and monitoring of vital signs in a supervised medical setting.

Therapeutic Uses of Qi Xin

What Qi Xin Treats: Main Uses and Benefits

Qi Xin (Mecobalamin) is a form of Vitamin B₁₂ commonly used in therapeutic settings to address conditions where additional symptomatic support is needed for conditions related to systemic or localized discomfort. Its therapeutic relevance is aligned with the role of Mecobalamin as a Vitamin B12 analogue, which is used in situations involving B12 deficiency and associated neurological symptoms.

Key Therapeutic Applications

This medication is relevant for symptomatic management across several domains, including peripheral neuropathies (such as diabetic neuropathy and neuralgia) and Vitamin B12 deficiency (which can lead to megaloblastic anemia). It is often applied when patients experience bothersome sensations like persistent tingling, numbness, and chronic fatigue—symptoms that interfere with daily functioning.

Quick Fact: Relief for Neuropathic Discomfort

This medication is commonly used to help with managing symptoms that create noticeable physiological strain and provides supportive relief when symptoms interfere with routine activities. It is applied when patients experience recurrent or fluctuating symptoms of nerve-related discomfort.

Eligibility and Restrictions for Use

Who can and cannot use Qi Xin?

The official regulatory profile for Qi Xin (Mecobalamin) establishes strict rules defining patient eligibility.

Contraindicated Populations

Use of Qi Xin is prohibited in certain groups. It is contraindicated for individuals with a known hypersensitivity to Mecobalamin, Cobalamin, or Cobalt, or any component of the product. Furthermore, the medicine is formally contraindicated for patients diagnosed with Leber's Disease.

Age-Related Eligibility

Eligibility is restricted for younger patients. Safety and effectiveness have not been established for the pediatric population, and use is consequently not recommended in children. The injectable form is contraindicated in infants due to formulation excipients. Use is generally established for adults, with conditional monitoring suggested for older adults.

Pregnancy and Lactation Status

Regarding reproductive health, pregnant individuals are advised to avoid use after the first trimester unless under the specific guidance of a medical professional. However, the medicine is generally considered safe for use by individuals who are breastfeeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of Qi Xin (Mecobalamin) primarily around substances that can interfere with its gastrointestinal absorption, leading to reduced systemic exposure. The medicine is formally contraindicated for use in patients with Leber's disease (hereditary optic neuropathy), as documented in prescribing information, due to the risk of worsening the condition.

Documented Exposure-Modifying Interactions

Co-administration with certain medicinal product categories is documented to compromise the absorption of Mecobalamin from the gut:

Gastric Acid Inhibitors: Medicines such as Proton Pump Inhibitors (PPIs) are noted to reduce Mecobalamin absorption by raising gastric pH.
Anticonvulsants: Specific antiseizure medicines, including Phenytoin and Carbamazepine, are documented to reduce the overall absorption of the B12 analogue.
Other Substances: Metformin is associated with reduced Vitamin B12 levels due to absorption interference. Likewise, the absorption of Mecobalamin may be reduced by co-administered medicines like Aminosalicylic acid or Colchicine.

Pharmacodynamic and Substance Interactions

Chloramphenicol may attenuate the expected antianemic effect of Mecobalamin by delaying the reticulocyte response. Heavy consumption of alcohol is also documented in regulatory sources as interfering with the absorption of the medicine. While no explicit timing rule is mandatory, regulatory information notes that co-administration with Vitamin C (Ascorbic Acid) might lower the available amount of Mecobalamin, suggesting potential separation.

Mechanism of Action

Qi Xin, which is composed of multiple bioactive compounds, exerts its effect through multi-target regulation in various tissues, including pulmonary systems. A key mechanistic pathway involves modulating the MAPK signaling cascade, specifically inhibiting the phosphorylation of ERK (Extracellular signal-regulated kinase).

Intracellularly, this inhibition downregulates the expression of pro-inflammatory mediators such as Interleukin-6 (IL-6) and Tumor Necrosis Factor (TNF). Furthermore, its compounds interact with targets like STAT3 and MMP9, resulting in a systemic shift away from cellular inflammatory and remodeling processes.

Downstream cascades include the suppression of IgE production and a reduction in the concentration of metabolites such as palmitic acid, which itself is linked to inflammatory signaling. This molecular regulation modifies cellular proliferation and secretory function in the airways, contributing to a modulation of airway hyperreactivity and tissue fluid dynamics at a system level.

Dosage and Administration Information

Qi Xin (Mecobalamin) is administered through two primary routes: Oral (via tablets or granules) or Parenteral (via Intramuscular or Intravenous injection). The choice of route and dose is detailed in prescribing information.

Administration Routes and Standard Dosing

For Oral Administration, the standardized adult dosage is typically 1,500 mcg per day. This total daily amount is usually administered in three divided doses, and the tablets may be taken with or without food.

The Parenteral Regimen involves a standard dose of 500 mcg per administration. This regimen is initiated on a three-times-per-week schedule. Following the initial treatment course, the use transitions into a maintenance phase where the 500 mcg dose is administered less frequently, typically once every one to three months.

Procedural Guidance

Procedural guidelines for injections specify that the injection site must be chosen carefully; for instance, administration should not occur at an innervated site, and repeated injections at the same location should be avoided. The dosage is subject to adjustment based on the patient’s age and presenting symptoms, though use in pediatric patients is not generally recommended without specialized consultation. These instructions define the required forms, precise quantities, and temporal patterns of usage as established by health authorities.

Recent Clinical Evidence

Research evidence / Overview of Studies for Qi Xin

Evidence for Use in Peripheral Neuropathy

Research exploring Mecobalamin, the active ingredient in Qi Xin, has been primarily conducted using Randomized Controlled Trials (RCTs) and subsequent systematic reviews. Studies were applied in research contexts involving fluctuating or unstable symptoms of nerve damage, often in adults with conditions such as diabetic neuropathy. Researchers examined patient-reported outcomes describing perceived discomfort, such as pain intensity, numbness, and tingling, as well as objective measurements like the speed at which electrical signals travel through nerves (Nerve Conduction Velocity).

Findings describe patterns observed in the studies where Mecobalamin administration was associated with changes measured by patient-reported symptom scales. Studies comparing Mecobalamin alone versus combination regimens reported that the objective nerve function tests demonstrated varied findings.

What remains uncertain is the durability of these reported short-term changes; long-term effects are not fully established beyond six months to one year. Additionally, the evidence quality varies across studies, and there is a need for more large-scale, high-quality, double-blind trials to provide clearer findings.

Evidence for Use in Vitamin B12 Deficiency

Mecobalamin was evaluated in individuals with confirmed Vitamin B12 deficiency, a condition characterized by fluctuating or episodic manifestations that can include neurological symptoms. Research examined outcomes related to systemic or functional imbalance by monitoring blood levels of B12 and associated markers, such as Homocysteine and Methylmalonic acid (MMA).

Studies examined how the administration of Mecobalamin correlated with measured changes in blood B12 levels and related metabolic markers in patients with a confirmed deficiency. Case studies and small cohorts described observed patterns of symptom evolution upon Mecobalamin administration in these studies, particularly in cases of overt deficiency where neurological symptoms were present.

Comparative evidence is lacking, as there are few controlled clinical trials directly comparing Mecobalamin to other forms of Vitamin B12 for neurological recovery. Furthermore, data are still emerging regarding the appropriate use and potential effects in cases of mild or subclinical deficiency where obvious neurological signs are not present.

What Is Still Uncertain About Qi Xin Research

Research highlights what is known—and what is still uncertain—about this medicine. The existing evidence contains several research limitation frames. These include inconsistency regarding objective outcomes (like Nerve Conduction Velocity improvements) versus subjective symptom reporting, and a lack of consistent long-term data to characterize the clinical course following chronic use.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Qi Xin (FAQ)

Q: Does Qi Xin need to be taken at a specific time of day?

Official drug labeling provides guidance on the oral administration of Qi Xin. The typical daily dose is usually split into three portions and is described as administered after meals. The labeling does not specify a mandatory time of day, such as morning or evening, but focuses on the relation to food intake.

Q: Do I need a special blood test before starting Qi Xin?

Official safety information indicates that Mecobalamin, the active ingredient, may potentially mask the signs of an underlying folate deficiency when administered in doses over 10 mug daily. This potential effect relates to the need for diagnostic clarity. Monitoring of blood status may be needed to ensure an accurate diagnosis before and during use.

Q: What is the difference between the active and inactive ingredients in Qi Xin?

Mecobalamin (Methylcobalamin) is the active ingredient that performs the primary function of the medicine. The drug formulation also contains inactive ingredients, or excipients, which are necessary for the product's stability and form. The complete list of these separate components is detailed in the official prescribing information.

Q: Can Qi Xin be taken if I have diabetes?

Studies and official sources describe Mecobalamin's use in research contexts involving conditions such as diabetic neuropathy. However, it is documented to interact with the common diabetes treatment, Metformin. This interaction may affect the absorption of Qi Xin.

Q: Can Qi Xin affect my sleep schedule?

Official documents list neurological adverse reactions, including anxiety and restlessness. Although these reactions are not specifically noted as sleep disorders, such effects may potentially interfere with a normal sleep schedule.

Q: Is it true that Qi Xin can cause dizziness?

According to the official product information, dizziness is listed as a possible adverse reaction to Qi Xin. As with many medicines, this type of effect is generally considered to be rare.

Q: What happens if I forget to take a dose of Qi Xin?

Official regulatory patient information includes specific directions on what to do if a scheduled dose is forgotten. These instructions are outlined in the patient information leaflet and address guidance for a forgotten dose.

Q: Can I drink coffee or tea while using Qi Xin?

Some regulatory-related patient counseling information includes a suggestion that the consumption of tea and coffee be avoided while using Qi Xin. This is based on concerns that certain substances in these beverages may affect the medicine’s absorption.

Q: Are there any specific foods I should avoid when taking Qi Xin?

Patient counseling information sometimes includes general advice regarding diet during treatment. These suggestions may include a suggestion to limit the intake of certain foods such as oily and canned items.

Q: Can Qi Xin be taken with common pain relievers like ibuprofen?

Official drug interaction databases used by health authorities do not currently document a specific interaction between Mecobalamin (the active ingredient in Qi Xin) and common Nonsteroidal Anti-inflammatory Drugs (NSAIDs), such as Ibuprofen.

Q: Does Qi Xin interact with blood thinners?

Official regulatory databases for drug interactions do not list Mecobalamin (Vitamin B12) as having a documented direct interaction with blood-thinning medications (anticoagulants).

Q: What is the official classification of Qi Xin (e.g., prescription only, controlled substance)?

The legal classification of Qi Xin (whether it is prescription-only or available over-the-counter) is determined by the health authority in each country. This regulatory decision governs how the product is supplied to patients.

Q: Has Qi Xin been studied in people with kidney disease?

Official safety information indicates that caution is required during administration of Qi Xin in patients who have a history of kidney disease. This is a standard constraint found in regulatory labeling that dictates conditional use.

Q: Does Qi Xin contain any common allergens like gluten or lactose?

Official regulatory labeling requires that the specific inactive ingredients, or excipients, used in the formulation are fully declared. This information is contained within the official Patient Information Leaflet.

Q: Does Qi Xin have any restrictions on driving or operating machinery?

According to official patient safety information, the active ingredient Mecobalamin is generally not expected to affect a patient's ability to drive or safely operate machinery. This information is typically included in the regulatory leaflet for public safety.

Q: If I have a history of mental health conditions, can I use Qi Xin?

Regulatory safety documents list neurological adverse reactions, including anxiety and restlessness, that may occur. These factors are relevant when discussing patient history.

Q: What happens if I accidentally take two doses of Qi Xin close together?

Official safety instructions for an accidental double dose specify contacting a healthcare professional or emergency services for guidance, as directed in the patient leaflet.

How should Qi Xin be stored and disposed of?

The storage and disposal of Qi Xin (Mecobalamin) must adhere strictly to official regulatory labeling to maintain the product's integrity.

Storage Requirements

The medicine must be stored at Controlled Room Temperature, which is typically 20 C to 25 C (68 F to 77 F), and not exceed 30 C.

Protection: Mecobalamin is sensitive; therefore, it must be protected from light and moisture and kept in a cool, dry place. Keep the medication in its original container with the cap tightly closed.
Safety: The product must be stored out of the sight and reach of children.

Disposal Instructions

Unused Product: Dispose of expired or unused Qi Xin according to local regulations. Do not discard the product by flushing it down the toilet or pouring it into a drain.
Environmental Constraint: Regulatory documents prohibit the material from contaminating ground water, surface water, or the sanitary sewer system.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

China

A-Z Index:

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z